# The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, Regulation 76: Limitation on withdrawal from pharmaceutical lists while fitness investigations or proceedings are ongoing


(1) If NHS England would otherwise remove an NHS chemist (C) from a pharmaceutical list under regulation 75, but—
(a) is investigating C in order to see whether there are grounds for exercising its powers in relation to C under section 151, 152 or 154 of the 2006 Act (which relate to disqualification of practitioners, contingent removal and suspension), or regulation 80;
(b) has decided to—
(i) remove C from a pharmaceutical list under section 151 or 152 of the 2006 Act or regulation 80, or
(ii) contingently remove C under section 152 of the 2006 Act,
but C has not yet been removed or contingently removed; or
(c) has suspended C under section 154 of the 2006 Act,
it must not, without the consent of the Secretary of State, remove C from that pharmaceutical list under regulation 75 until the relevant investigation or proceedings have been concluded.
(2) If C's name is kept on a pharmaceutical list pursuant to paragraph (1)—
(a) as regards C, NHS England may exercise its functions under—
(i) Part 11 of these Regulations, and
(ii) Chapter 6 of Part 7 of the 2006 Act (pharmaceutical services and local pharmaceutical services – disqualification); but
(b) for all other purposes, C is to be treated as having been removed from that pharmaceutical list under regulation 75.

---
Source: https://www.legislation.gov.uk/uksi/2013/349/regulation/76 (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-76
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

